Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.

Annals of biomedical engineering - 1 Aug 2021

Amirghasemi Farbod, Adjei-Sowah Emmanuela, Pockaj Barbara A, Nikkhah Mehdi

Abstract excerpt

The burden of cancer continues to increase in society and negatively impacts the lives of numerous patients. Due to the high cost of current treatment strategies, there is a crucial unmet need to develop inexpensive preclinical platforms to accelerate the process of anti-cancer drug discovery to improve outcomes in cancer patients, most especially in female patients. Many current methods employ expensive animal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Drug Screening Assays, Antitumor

Share to Glioblastoma

Share to Neoplasm Metastasis

Share to Tissue Engineering

Share to Tumor Microenvironment

Source

Identifiers

PMID: 33403451
DOI: 10.1007/s10439-020-02704-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.PMID 33403451Read ↗

Microfluidic modelling of the tumor microenvironment for anti-cancer drug developmentSemantic proximity Read ↗

Breaking the mold: 3D cell cultures reshaping the future of cancer researchSemantic proximity Read ↗

A microfluidic platform for functional assays on tumour biopsy-derived spheroids for precision medicineSemantic proximity Read ↗

Evaluation of Tumor Response to Adjuvant Treatments using an Ex Vivo Culture of Breast Carcinoma Spheroids in a Microfluidic DeviceSemantic proximity Read ↗

The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid TumorsSemantic proximity Read ↗

Rapid Microfluidic Formation of Uniform Patient-Derived Breast Tumor SpheroidsSemantic proximity Read ↗

Microfluidic Platform for Drug Response Profiling in NSCLC Patient-Derived OrganoidsSemantic proximity Read ↗

Tumoroid-on-a-Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic ScreeningSemantic proximity Read ↗

Non-Animal Models for Studying the Effects of Chemotherapeutic Drugs on Breast Cancer MetastasisSemantic proximity Read ↗

Preclinical Testing Techniques: Paving the Way to New Oncology Screening ApproachesSemantic proximity Read ↗

A 3D microtumour system that faithfully represents ovarian cancer minimal residual diseaseSemantic proximity Read ↗

Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.